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Trans-ethnic study design approaches for fine-mapping
Jennifer L Asimit1, Konstantinos Hatzikotoulas1, Mark McCarthy2, Andrew P Morris2,3 and
Eleftheria Zeggini*,1
Studies that traverse ancestrally diverse populations may increase power to detect novel loci and improve fine-mapping resolution
of causal variants by leveraging linkage disequilibrium differences between ethnic groups. The inclusion of African ancestry
samples may yield further improvements because of low linkage disequilibrium and high genetic heterogeneity. We investigate
the fine-mapping resolution of trans-ethnic fixed-effects meta-analysis for five type II diabetes loci, under various settings of
ancestral composition (European, East Asian, African), allelic heterogeneity, and causal variant minor allele frequency. In
particular, three settings of ancestral composition were compared: (1) single ancestry (European), (2) moderate ancestral
diversity (European and East Asian), and (3) high ancestral diversity (European, East Asian, and African). Our simulations
suggest that the European/Asian and European ancestry-only meta-analyses consistently attain similar fine-mapping resolution.
The inclusion of African ancestry samples in the meta-analysis leads to a marked improvement in fine-mapping resolution.
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INTRODUCTION
Numerous genome-wide association studies (GWASs) have been
carried out, resulting in the identification of many susceptibility loci
for a wide range of complex traits.1 The detection of additional loci
has resulted from GWAS meta-analyses (primarily in populations of
European descent) and has been aided by imputation that allows the
prediction of genotypes not typed on GWAS chips, but present in a
higher density reference. Nonetheless, the joint effects of the loci
identified to date have only accounted for a small proportion of the
heritability of complex traits. Because of linkage disequilibrium (LD),
many variants within identified loci have indistinguishable signals.
This LD is beneficial to GWAS, as it increases the power to detect new
associations, when the causal variant is not directly typed. However,
the caveat to this is that it limits the potential of fine-mapping efforts
to refine the location of causal variants.
GWAS data from non-European populations are increasing in
availability, and this provides the opportunity to meta-analyse GWAS
across ancestrally diverse populations. Trans-ethnic meta-analysis may
lead to an increase in power to detect novel loci and may improve
fine-mapping resolution of causal variants by leveraging differences in
the structure of LD between diverse populations.2,3 The inclusion of
African ancestry samples may yield substantial improvements in
localisation of causal variants because of low LD and high genetic
heterogeneity.4
Several trans-ethnic analyses have shown empirical improvements
in fine-mapping resolution. Examples include a refinement of signals
at several type II diabetes loci in an analysis involving samples of
European, East Asian, South Asian, and Mexican and Mexican-
American ancestry,5 as well as in previously identified adiposity loci
in a trans-ethnic meta-analysis of samples from European and African
ancestries.6 Similarly, a refinement of signals was obtained at several
lipid trait loci in a trans-ethnic fine-mapping study involving African-
American, East Asian, and European ancestries.7 However, a compar-
ison of study designs, where the ancestral composition of the samples
varies in diversity whereas the same number of samples (and cost) is
constant, has not yet been performed. Approaches to meta-analysis
include a fixed- or random-effects model, as implemented in
GWAMA (genome-wide association meta-analysis8) or MANTRA
(Meta-ANalysis of Trans-ethnic Association studies), that allows for
heterogeneity in allelic effects between distantly related populations.9
We focussed on fixed-effects meta-analysis, as trans-ethnic studies of
complex traits demonstrated relatively little evidence of heterogeneity
in allelic effects at common variant loci. Moreover, MANTRA and
fixed-effects GWAMA have been shown to have similar power when
the variant has a non-null effect in all of the populations.10 Therefore,
our objective is to examine different study designs with respect to
ancestral composition, rather than statistical approaches to meta-
analysis. There may be power and fine-mapping advantages in
increasing the ancestral diversity among the samples while retaining
the same number of samples and cost.
We carried out an extensive simulation study to examine different
study designs with respect to ancestral composition (European, East
Asian, and African) to assess any power and fine-mapping advantages
due to increasing ancestral diversity among samples while retaining the
same number of samples and cost. The aim is to determine whether
trans-ethnic meta-analyses offer fine-mapping resolution advantages
over single ancestry meta-analyses, and whether or not any gains are
due to the inclusion of African ancestry samples.
MATERIALS AND METHODS
We focus on five established type II diabetes (T2D) loci (IGF2BP2, CDKN2A/B,
KCNQ1, FTO, CDKAL1). These loci were explicitly chosen as they have
association signals present in multiple ethnic groups,11 and several of these loci
have shown large differences in LD between ethnic groups (eg, CDKAL1 and
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KCNQ1). Such loci characteristics are likely to favour success for trans-ethnic
meta-analyses.
In this simulation study, trans-ethnic meta-analysis was carried out by a
frequentist fixed-effects meta-analysis that was implemented in GWAMA8 as a
proof of principle in comparing fine-mapping of studies having varying degrees
of ancestral diversity. In addition, for completeness, we also employed
GWAMA using random effects in a selection of settings. Fine-mapping
assessment was examined when the variant had a non-null effect in all of the
populations and under various levels of ancestral diversity: European-only
samples; moderate ancestral diversity (European and Asian samples); and high
ancestral diversity (European, East Asian, and African samples).
Simulation settings
Sets of six cohorts were meta-analysed across five loci under various allelic
heterogeneity models and ancestry compositions of the contributing cohorts.
Data were simulated using Hapgen212 from 6 populations based on the 1000
Genomes June 2011 haplotypes:13 CEU, TSI (European reference panels (RPs)),
CHB, JPT (East Asian RPs), LWK, and YRI (African RPs). Each cohort was
composed of 1000 cases/1000 controls, and 1000 replications were used for
each setting. These simulations represent directly typed data, and variants are
referred to as perfect. They were then thinned down to GWAS density based on
the SNPs in the Illumina 660-Quad array, and subsequently imputed via
IMPUTE2,14 using the same cross-population 1000 Genomes reference panel,
and effective population size Ne= 20 000. A 500 kb up- and down-stream
buffer was included in the imputation, and variants with SNPTEST proper
information score below 0.4 were filtered out. Both perfect (all variants are
directly typed) and imputed data were analysed. Analysis of the perfect data
illustrates an optimal scenario and provides the maximum possible power and
refined fine-mapping resolution that may be attained, whereas the imputed data
represent a more realistic setting.
There were three general ancestry combinations considered for meta-
analysis:
1. Single ancestry (European): 6 CEU samples;
2. Moderate ancestral diversity (European and Asian): 3 CEU+TSI samples,
3 CHB+JPT samples; and
3. High ancestral diversity (European, Asian, and African): 1 sample from each
of CEU, TSI, CHB, JPT, LWK, and YRI.
Within each locus, causal variants were selected within ± 0.5% of one of
three minor allele frequencies (MAFs): 5, 10, or 20%, with respective relative
risks of 1.4, 1.3, and 1.2. As the MAF varies between the populations, when
there was a shared causal variant c1, it was selected to satisfy the MAF
requirements in the CEU population frequency and to be nonmonomorphic in
the other populations. A single causal variant c1 was considered for each of the
single ancestry and moderate and high ancestral diversity scenarios.
Meta-analysis and fine-mapping
Within each study sample, single SNP association tests were carried out with an
additive model in a ‘missing data likelihood’ framework, as implemented in
SNPTEST v2.15 As put into practice in GWAMA,8 the frequentist fixed-effects
meta-analysis of the single SNP summary statistics assumes that the allelic effect
at SNP j is the same across all samples. This meta-analysis approach is highly
computationally efficient, but has the limitation that it assumes a homogeneous
effect size among all of the samples.
A measure of fine-mapping resolution was based on the construction of 95%
credible sets using Bayesian theory, such that the sets were 95% likely to
encompass the causal SNP. In order to form the credible sets, the association
summary statistics (b^ and its variance, V) from each SNP were first converted
to an approximate Bayes’ factor (ABF):
ABF ¼
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V
p ,b^~N(β,V),β~N(0,W) and N(μ,σ2) denotes that the random
variable follows a Normal distribution with mean μ and variance σ2.16 For a
case–control study and an additive model, a widely used default value is
W= 0.04.15 Evidence against the null hypothesis increases with the ABF value,
and posterior probabilities were calculated from the ratio of the individual ABF
value to the sum of the ABF values for all SNPs within the region. These
posterior probabilities were then ranked in decreasing order and SNPs were
consecutively collected to form a 95% credible set until the total of the posterior
probabilities for the SNPs in the set first exceeded 0.95.17
We only constructed 95% credible sets when the lead SNP had a P-value
below a prespecified threshold in order to avoid the construction of sets
consisting only of SNPs that are unlikely to be disease associated. The
construction of credible sets based on lead SNPs with weak signals requires a
larger number of SNPs to meet the criterion of a certain total posterior
probability, as the individual SNP posterior probabilities tend to be small in this
case. For computational efficiency, we focussed on a frequentist threshold for
the decision of whether or not to construct a credible set. This avoided an
additional computational step of ABF calculations that would not be required if
it was inappropriate to construct a credible set.
In assessing any effect of ancestral diversity on fine-mapping resolution, the
probability of the causal variant being a member of the 95% credible set was
assessed among simulation scenarios in which all samples shared a causal
variant. For each region, the median number of SNPs within credible sets that
contained the true causal variant was considered in evaluating the refinement
for localising the causal variant within the locus; a smaller number is indicative
of higher fine-mapping resolution. As a means of combining the measures over
the regions, we refer to the average of the region-specific medians as a summary
statistic.
Effects of allelic heterogeneity were investigated by introducing a different
causal variant c2 for the Asian samples, such that it was of similar MAF, but in
low LD (r2o0.2) with the European causal variant. In particular, for the
moderate ancestral diversity scenario, we compared the setting of no hetero-
geneity, where c1 is the causal variant for both European and East Asian
samples, with the allelic heterogeneity setting of causal variant c1 for European
samples and causal variant c2 for East Asian samples.
To reflect locus heterogeneity, in the high ancestral diversity set-up we
assumed null associations at both c1 and c2 for the African samples; we refer to
such cohorts as null. In these heterogeneity scenarios we examined the impact
on power to detect the variant that is causal in the European samples. We
compared the settings of no heterogeneity (causal variant c1 in all samples),
allelic and locus heterogeneity (causal variants c1 in European samples and c2
for East Asian samples; null for African samples), and locus heterogeneity
(causal variant c1 in European samples; null for East Asian and African
samples). For both types of heterogeneity, comparisons are also made with the
power to detect a causal variant in the single ancestry (European) composition
to assess the power loss of trans-ethnic meta-analyses in the presence of
heterogeneity.
RESULTS
In the decision for construction of 95% credible sets, a stringent lead
SNP P-value threshold of 5× 10− 8 was employed. The probability that
the 95% credible set contained the true causal variant was high across
all five loci and there was no clear collective pattern between
probabilities and degree of ancestral diversity. Upon collapsing the
individual region results into averages over the regions, any differences
were smoothed over and there were negligible differences between the
probabilities for the various diversity settings at a given causal variant
MAF (Table 1). For the high diversity scenario with perfect data, a
random-effects meta-analysis was also implemented using GWAMA.
The summary measure over the five regions of the probability that the
95% credible set contains the causal variant drops slightly with
random effects, compared with fixed effects, and the standard error
of these estimates are slightly higher for random effects. The respective
summary probabilities for MAFs 5, 10, and 20% are 0.911, 0.900, and
0.912 (with standard errors 0.00437, 0.00453, and 0.00489) for
random effects, whereas the coinciding probabilities for fixed effects
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are 0.930, 0.910, and 0.928 (with standard errors 0.00395, 0.00421,
and 0.00440).
Next, we examined the median number of SNPs in the credible sets
for each region. Summary measures over the regions are provided in
Table 2, and individual region results are available in Supplementary
Table S1. Boxplots displaying the distribution of the number of SNPs
in 95% credible sets are given for summary measures and individual
loci in Figures 1 and 2 for perfect and imputed data, respectively. That
is, each summary measure boxplot gives the distribution of the median
number of SNPs in the 95% credible sets constructed for each locus,
whereas the individual loci boxplots display the distributions for the
number of SNPs in the 95% credible sets. The summary statistics
suggested that the high ancestral diversity meta-analysis had the
smallest median number of SNPs in 95% credible sets, regardless of
causal variant MAF and whether or not the data were imputed; at
MAF 10%, for increasing levels of diversity, the perfect data summary
medians were 2, 3, and 1, whereas for imputed data they were 3.6, 3,
and 1.6 (Table 2). In most of the individual region analyses, the highly
diverse ancestral composition meta-analysis achieved the smallest
median or the same median as the moderate ancestral diversity
meta-analysis (Supplementary Table S1). In the random-effects meta-
analyses of the high diversity setting for perfect data, the summary
measures over the five loci for the median number of SNPs in the 95%
credible sets were 1.6, 1.0, and 2.8 at MAFs 5, 10, and 20%,
respectively; the credible sets constructed from the random-effects
meta-analyses are similar to those for fixed effects. The locus-level
results are not presented for this random-effects (RE) analysis, as they
are identical to the fixed-effects (FE) analysis, except for smaller
medians at MAF 20% for CDKAL1 (RE 5 SNPs; FE 6 SNPs) and at
MAF 5% for FTO (RE 4 SNPs; FE 5 SNPs).
Within each region we used the Kruskal–Wallis rank sum test to
assess the evidence for the null hypothesis that the median was the
same in each ancestral setting group against the alternative that at least
one group had a different median. If there was evidence of a
difference, Dunn’s test was then applied to test each of the pairwise
comparisons for the null hypothesis that, with probability 0.5, a
random SNP count from the first group is larger than one from the
second group. This may be interpreted as a test for one group having a
larger median than the other.
The Kruskal–Wallis test, applied to perfect data, resulted in strong
evidence (P-value o105) that at least one ancestral setting had a
median SNP count different from the others, with the exception of
one region and MAF setting. Similarly high levels of significance
(P-value o105) were attained for all imputed data settings.
In both perfect and imputed data, for each region with a causal
variant having MAF 10% or 20%, Dunn’s test gave strong evidence
(P-value o105) of the high ancestral diversity group having a lower
median than the single ancestry group. This was also true at the
lower MAF for each region, except for only moderate evidence at
CDKN2A/B (perfect and imputed data P-values 0.0302 and 0.0973).
There was not a clear trend between the European and European/
Asian meta-analyses, as either group was found to have strong support
(P-value o105) for a larger median or no evidence (P-value 40.1)
for a difference in medians for various MAFs and regions.
As each gene may differ in LD structure, we paired the medians of
each ancestral diversity comparison according to gene, and then tested
whether the region medians of lower ancestral diversity settings had a
greater average than those of higher ancestral diversity via a paired
t-test. Detailed results are given in Supplementary Table S2. For
perfect data, over all MAF settings, there was moderate evidence
(considering the small sample size of 5 regions) that the regional
median numbers of SNPs in credible sets were on average larger in
European-only meta-analyses than in those that include African and
East Asian ancestry samples (P-values 0.071, 0.045, and 0.035 for
MAFs 5, 10, and 20%, respectively). Imputed data had similar levels of
evidence (P-values 0.023 and 0.047 for MAFs 5 and 20%, respectively)
and considering 0.05 Bonferroni-corrected threshold of α= 0.011 for
the three pair-wise comparisons, this holds with strong evidence for
MAF 10% (P-value 5.5E-03). The results also suggested that the
European/Asian trans-ethnic meta-analysis did not have a greater
fine-mapping refinement than the European-only meta-analysis,
except for moderate evidence in the low MAF setting of imputed
data (P-value 0.032). There was moderate evidence for a higher
median in European/Asian compared with European/Asian/African at
MAF 5% (P-values 0.051 and 0.069 for perfect and imputed data,
respectively).
As we found a clear improvement in the trans-ethnic meta-analyses
composed of European, East Asian, and African populations, but not
in those without African samples, we also investigated fine-mapping in
Table 1 Summary measure (and SE) over the five regions of the probability that the causal variant is in the 95% credible set
Ancestry combination Data type MAF 5% MAF 10% MAF 20%
Single (Eu) Perfect 0.944 (0.00367) 0.894 (0.00447) 0.929 (0.00426)
Imputed 0.864 (0.00768) 0.815 (0.00650) 0.892 (0.00562)
Moderate (Eu/EA) Perfect 0.922 (0.00558) 0.903 (0.00442) 0.936 (0.00410)
Imputed 0.894 (0.00644) 0.846 (0.00567) 0.920 (0.00490)
High (Eu/Ea/Af) Perfect 0.930 (0.00395) 0.910 (0.00421) 0.928 (0.00440)
Imputed 0.892 (0.00517) 0.845 (0.00559) 0.853 (0.00618)
Single (Af) Perfect 0.941 (0.00358) 0.929 (0.00404) 0.921 (0.00541)
Perfect and imputed data results are given in the upper and lower portion of each cell, respectively. Credible sets were constructed only when the lead SNP had P-value below 5E−08.
Table 2 Summary measure of the medians over the five regions for
the regional median number of SNPs in the 95% credible sets
Ancestry combination Data type MAF 5% MAF 10% MAF 20%
Single (Eu) Perfect 4.6 2.0 7.8
Imputed 8.2 3.6 9.0
Moderate (Eu/EA) Perfect 3.8 3.0 10.8
Imputed 4.2 3.0 11.6
High (Eu/Ea/Af) Perfect 1.8 1.0 3.0
Imputed 2.4 1.6 4.6
Single (Af) Perfect 1.0 1.0 1.6
Perfect and imputed data results are given in the upper and lower portion of each cell,
respectively. Credible sets were constructed only when the lead SNP had P-value below 5E−08.
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African-only meta-analyses of perfect data. Based on the same
simulation setting of 1000 cases/1000 controls for each sample and
the same causal variants (based on European populations), where
three samples are taken from each of the LWK and YRI populations,
we found that the proportion of 95% credible sets that contain the
causal variant is similarly high for the various ancestral diversity
settings. However, the standard errors of these probabilities are slightly
higher for the African-only samples, as there are fewer replications in
which the lead SNP passes the P-value threshold of 5 × 108 (Table 1).
In addition, the median tends to be lowest in the African-only meta-
analyses (see Table 2 for summaries and Supplementary Table S1 for
individual loci).
Fine-mapping resolution is most refined for African-only meta-
analyses, suggesting that features of the African populations such as
lower LD rather than ethnic diversity are the underlying source of
improvement in the high diversity settings. The allele spectrum
between the populations was also examined; for the various European
causal variant MAF settings, the median MAFs for the East Asian and
African samples are provided in Supplementary Table S3. The median
MAF in the African samples tends to be larger than that of the
European samples, whereas the median MAF in the East Asian
samples tends to be similar or larger in comparison with European
samples. However, there is no clear pattern related to MAF and fine-
mapping improvement, indicating that this improvement is more
related to LD.
We also examined the effects of ancestral diversity on power
to detect an association with a variant that was causal in all
samples. At significance level 0.05, regardless of the level of
ancestral diversity among the samples, a power close to or
identically 100% was attained for both perfect and imputed data,
respectively. Upon repeating the meta-analysis with random
effects for IGF2BP2 in the high ancestral diversity setting and for
the three MAF settings, identical power results of 1.0 were attained
for perfect data.
Figure 1 Boxplots, for perfect data, of the number of SNPs in the 95% credible sets for summary measures of the five loci and for individual loci at MAFs 5,
10, and 20% and ancestral diversities single, moderate, and high.
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For imputed data, the causal variant may either be a tag SNP, so
that it is directly typed, or it may be imputed. Among the replications
for imputed data, upon examination of the power only at the imputed
causal variants, there are not substantial differences compared with the
power at directly typed variants. For instance, when the causal variant
is the same across all ancestries and diversity settings, the power
remains close to 1.0 at imputed-only causal variants, except that at
MAF 5% the power is slightly lower for single ancestry in FTO (4%
lower) and in CDKN2AB (8% lower). In the presence of locus or
allelic heterogeneity, there are also very few differences in power
between imputed and directly typed causal variants; at MAF 5%, there
is occasionally a power reduction near 10% when causal variants are
imputed rather than directly typed. As the differences are not
substantial, this subset of results from the imputed data is not
provided.
The effect of allelic heterogeneity on the power to detect a causal
variant was assessed by comparing the moderate ancestral diversity
scenario in which both Europeans and Asians shared the same causal
variant, against the setting in which they had different causal variants
in low LD with one another. In the moderate diversity setting, power
losses from the presence of allelic heterogeneity in half of the samples
ranged from 10% in perfect data up to 23% in imputed data,
irrespective of MAF (Table 3); these same losses are observed between
single ancestry and allelic heterogeneity in the moderate diversity
setting when the data are perfect and at MAFs 10 and 20% in imputed
data. Specifically, in individual regions, perfect data had power losses
from allelic heterogeneity between 3.8 and 26.2%, with median 12.3%.
For imputed data, power losses from moderate diversity with
heterogeneity over that without heterogeneity (or single ancestry)
are between 5.7% (5.6%) and 33.2% (33.2%) with median 16.4%
(16.2%). At MAF 5%, in imputed data, the power for the single
ancestry setting is on average 2.6% lower than that of the setting in
which there is no heterogeneity in the moderate diversity setting.
Upon repeating the meta-analysis with random effects for IGF2BP2 in
the presence of allelic heterogeneity and for perfect data, there was a
larger power reduction; fixed-effects meta-analyses yielded powers of
Figure 2 Boxplots, for imputed data, of the number of SNPs in the 95% credible sets for summary measures of the five loci and for individual loci at MAFs
5, 10, and 20% and ancestral diversities single, moderate, and high.
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0.819, 0.886, and 0.865 at respective MAFs of 5, 10, and 20%, whereas
the coinciding powers from random-effects meta-analyses were 0.73,
0.795, and 0.51.
In the locus heterogeneity scenario, we found that null cohorts (East
Asian, African) had a dramatic impact on the power to detect the
causal variant that was associated in only two (European) of the six
cohorts (Table 4). In both perfect and imputed data, the average
power loss over the regions was ∼ 50%, irrespective of the MAF. The
individual region power reductions for perfect data were between 45.7
and 67.9%, with median 60.6%, whereas imputed data had power
losses between 52.5 and 75.9%, with median 60.3%. Slightly larger
power losses were observed when there was both locus and allelic
heterogeneity (different causal variants for European and East Asian,
African null cohort), as detailed in Table 4. These results are
comparable to previous results10 where a fixed-effects analysis of all
populations attained a power of 99.7%, whereas the power dropped by
69.3% when African and East Asian samples were null strata. The
power losses from the inclusion of samples with a null association at
the variant suggest that locus heterogeneity may have a more profound
effect on power compared with allelic heterogeneity. Similar power
losses are observed in comparing the single ancestry scenario with any
of the heterogeneity settings in the high diversity scenario, as there are
negligible differences between the powers of the single ancestry and
high diversity ancestral composition in the absence of heterogeneity.
The manner in which the credible set is constructed makes the
assumption of a common causal variant that does not hold in the
heterogeneity settings, such that a low fine-mapping resolution is
expected in these settings. As an illustration, credible sets were
constructed when there is moderate diversity and allelic heterogeneity
in IGF2BP2, as well as both allelic and locus heterogeneity in the high
diversity scenario. Presence of the signal in only one group (Eu)
resulted in very large 95% credible sets, consisting of at least 1500
variants (results not provided). Use of random effects rather than fixed
effects reduced the size of the credible sets by ∼ 200 SNPs, but credible
sets were constructed in o10% of the replications; few replications
had a SNP that passed the genome-wide significance threshold.
DISCUSSION
There is a clear improvement in fine-mapping resolution when
synthesising data across highly diverse samples (European/Asian/
African) in comparison with the analyses of samples from the same
ancestry (European). A clear trend of increased fine-mapping
resolution is not apparent in comparisons between common ancestry
meta-analyses and those consisting of samples of European and Asian
ancestry. This may be because of individuals of European and Asian
ancestry being more closely related with each other than with those of
African ancestry, as had been illustrated in previous relatedness
analyses.9 These results indicate that the meta-analysis of ancestrally
diverse samples results in an improvement in fine-mapping resolution,
provided that the composition includes those of African ancestry. For
further investigation of this improvement, we examined African-only
meta-analyses that displayed a high fine-mapping resolution, suggest-
ing that increasing the sample size of African ancestry samples is more
likely to improve fine-mapping resolution than increasing sample
diversity. It would also be of interest to investigate the inclusion of
Hispanic cohorts, given the current efforts in establishing large
Hispanic cohorts, the admixing history, and ethnic diversity within
such cohorts. Given the fine-mapping improvements observed from
the inclusion of African ancestry samples, and that the LD levels in
Hispanic samples tend to fall between those of Africans and
Europeans/East Asian, inclusion of Hispanic samples is expected to
contribute to refinement in fine-mapping over that of European and
East Asian samples.
Methods for trans-ethnic meta-analyses have been compared in
extensive simulation studies,10 yet the impact of ancestral composition
in study design has not previously been investigated. Although the
conducted simulation studies are limited by taking place under an
ideal scenario in which imputation reference panels consist of
populations that are exact matches for the study samples, they act as
a gauge for the performance of the various ancestral composition
study designs. This study highlights the benefits of trans-ethnic meta-
analysis for detecting novel complex trait loci and fine-mapping causal
variants, when there is a shared causal variant. It also considers the
effect on power from the inclusion of cohorts where the variant is null
that may occur if it was discovered in African populations and did not
segregate outside of Africa, or vice versa. In this case, the fixed-effects
(and random-effects) meta-analysis is exposed to a dramatic power
loss when the sample size is fixed over the different ancestral diversity
scenarios. Therefore, when there is a restriction on sample size
(eg, cost), careful consideration is needed in designing the ancestral
Table 3 Over the five regions, the mean power to detect the variant
that is causal in the European samples c1 (at significance level 0.05)
in the absence/presence of allelic heterogeneity; positive detection
occurs when the P-value for the single variant test at c1 is below 0.05
Sample composition and causal
variants
Data
type
MAF
5%
MAF
10%
MAF
20%
Eu-c1 (single ancestry) Perfect 1.000 1.000 1.000
Imputed 0.970 0.999 0.999
Eu/EA-c1 (no heterogeneity) Perfect 1.000 1.000 1.000
Imputed 0.996 1.000 0.999
Eu-c1, EA-c2 (allelic heterogeneity) Perfect 0.892 0.870 0.832
Imputed 0.862 0.829 0.775
Perfect and imputed data results are given in the upper and lower portion of each cell,
respectively. The sample compositon for each meta-analysis includes European (Eu) and East
Asian (EA) whereas causal variants are denoted by c1, and c2, respectively, for association at
c1 and c2.
Table 4 Summary measure over the five regions of the power to
detect the variant that is causal in the European samples c1 (at
significance level 0.05) in the presence of allelic and locus
heterogeneity; positive detection occurs when the P-value for the
single variant test at c1 is below 0.05
Sample composition and causal variants
Data
type
MAF
5%
MAF
10%
MAF
20%
Eu-c1 (single ancestry) Perfect 1.000 1.000 1.000
Imputed 0.970 0.999 0.999
Eu/EA/Af-c1 (no heterogeneity) Perfect 1.000 1.000 1.000
Imputed 0.998 1.000 0.999
Eu-c1, EA-c2, Af-0 (allelic and locus
heterogeneity)
Perfect
Imputed
0.419
0.257
0.494
0.426
0.412
0.359
Eu-c1, EA/Af-0 (locus heterogeneity) Perfect 0.413 0.539 0.432
Imputed 0.320 0.495 0.399
Perfect and imputed data results are given in the upper and lower portion of each cell,
respectively. The sample compositon for each meta-analysis includes European (Eu), East Asian
(EA), and African (Af), whereas causal variants are denoted by 0, c1, and c2, respectively, for
null data, association at c1, and association at c2.
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composition for the meta-analysis, depending on the assumption of
shared causal variants or locus heterogeneity.
Meta-analyses are often performed with an intention of maximising
the number of available cohorts, with or without African ancestry
cohorts. This is often owing to the restricted opportunities to include
African cohorts, either because of GWAS data not existing or not
readily available for sharing and for meta-analysis. Our simulation
results indicate the importance of including African ancestry samples
in fine-mapping studies, and that high gains in resolution are possible
with their inclusion. Considering the high resolution in the African-
only analyses, it may be beneficial to include a few small African
cohorts (eg, size 1000 each) rather than an additional couple of large
European cohorts (eg, size 410 000). The possibility of deriving
benefits that have a global impact may therefore be more likely by
developing the capacity for genomic sciences in Africa, such that an
increased number of African-focussed GWASs may be performed.
This includes enabling and empowering more African researchers to
carry out such studies in their populations.
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